Welcome to the Website for the Network
on Antimicrobial Resistance in Staphylococcus aureus
(NARSA). The NARSA program is
funded by the National
Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)
and is designed to support and facilitate critical research efforts among
clinical and basic scientists from the academic, industrial, and public
health sectors regarding staphylococcal infections and disease.
The NARSA program has established an
infrastructure that supports cross fertilization of biological, medical, and
epidemiological research directed towards understanding antimicrobial
resistance and other medically relevant genetic and physiological characteristics
This infrastructure includes:
A continuously expanding, centralized
Repository of strains exhibiting reduced susceptibility to vancomycin and
other characteristics of research and clinical importance and interest.
A database of microbiologic and
clinical information that accompanies the Repository of strains.
A Website that provides Registered
1) access to the
NARSA Repository database.
2) ability to
peruse the isolate inventory catalog and order available isolates.
3) links to
other key sources of information regarding staphylococcal research.
4) a forum for
investigators to share and relate their findings and knowledge about recent
advances in staphylococcal research.
5) access to
contact information and research interests of other Network participants.
In order to gain access to the isolates
available in NARSA's Repository, to view the data collected and maintained
for these isolates, and to interact with other Network participants,
you must Register
with the program. For additional
information or questions concerning NARSA, please see the Program Synopsis or Contact
NARSA is managed by Eurofins Global Central Laboratory